shares in this article
On April 7, 2022, Cathay Biotech A disclosed the results for the quarter ended December 31, 2021.
Earnings per share for the full year were reported at CNY 1.46. In the previous year, earnings per share were CNY 1.14.
Cathay Biotech A closed the past fiscal year with total sales of CNY 2.20 billion. According to this, the company increased its sales by 46.76 percent compared to the previous year, in which 1.50 billion CNY were generated.
Analysts had expected earnings of CNY 1.54 per share for the past year as a whole. They put the sales estimate for the full year at 2.35 billion CNY.
Editorial office finanzen.net
Selected Leverage Products on Cathay Biotech Inc. Registered Shs -A-With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired lever and we will show you suitable products on Cathay Biotech Inc. Registered Shs -A-
Leverage must be between 2 and 20
No data
